Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. Convergence of costimulatory signals and differences from transformed T cells - PubMed (original) (raw)
Comparative Study
. 1996 Mar 8;271(10):5369-77.
doi: 10.1074/jbc.271.10.5369.
Affiliations
- PMID: 8621390
- DOI: 10.1074/jbc.271.10.5369
Free article
Comparative Study
Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. Convergence of costimulatory signals and differences from transformed T cells
C C Hughes et al. J Biol Chem. 1996.
Free article
Abstract
To study transcriptional regulation in normal human T cells, we have optimized conditions for transient transfection. Interleukin-2 (IL-2) promoter-reporter gene behavior closely parallels the endogenous gene in response to T cell receptor and costimulatory signals. As assessed with mutagenized promoters, the most important IL-2 cis-regulatory elements in normal T cells are the proximal AP-1 site and the NF- kappaB site. Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements. Interestingly, the nuclear factor of activated T cell sites are much less important in normal T cells than in Jurkat T cells. We conclude that IL-2 transcriptional regulation differs in tumor cell lines compared with normal T cells and that different costimulatory signals converge on the same cis-elements in the IL-2 promoter.
Similar articles
- Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.
Parra E, Varga M, Hedlund G, Kalland T, Dohlsten M. Parra E, et al. Mol Cell Biol. 1997 Mar;17(3):1314-23. doi: 10.1128/MCB.17.3.1314. Mol Cell Biol. 1997. PMID: 9032258 Free PMC article. - Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
Zhou XY, Yashiro-Ohtani Y, Nakahira M, Park WR, Abe R, Hamaoka T, Naramura M, Gu H, Fujiwara H. Zhou XY, et al. J Immunol. 2002 Apr 15;168(8):3847-54. doi: 10.4049/jimmunol.168.8.3847. J Immunol. 2002. PMID: 11937538 - A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB.
Zhao J, Freeman GJ, Gray GS, Nadler LM, Glimcher LH. Zhao J, et al. J Exp Med. 1996 Mar 1;183(3):777-89. doi: 10.1084/jem.183.3.777. J Exp Med. 1996. PMID: 8642282 Free PMC article. - GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells.
Shannon MF, Himes SR, Coles LS. Shannon MF, et al. J Leukoc Biol. 1995 May;57(5):767-73. doi: 10.1002/jlb.57.5.767. J Leukoc Biol. 1995. PMID: 7759956 Review.
Cited by
- Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.
Pahl A, Zhang M, Kuss H, Szelenyi I, Brune K. Pahl A, et al. Br J Pharmacol. 2002 Apr;135(8):1915-26. doi: 10.1038/sj.bjp.0704656. Br J Pharmacol. 2002. PMID: 11959794 Free PMC article. - Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1.
Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C. Ayroldi E, et al. Mol Cell Biol. 2002 Nov;22(22):7929-41. doi: 10.1128/MCB.22.22.7929-7941.2002. Mol Cell Biol. 2002. PMID: 12391160 Free PMC article. - CD58 Immunobiology at a Glance.
Zhang Y, Liu Q, Yang S, Liao Q. Zhang Y, et al. Front Immunol. 2021 Jun 8;12:705260. doi: 10.3389/fimmu.2021.705260. eCollection 2021. Front Immunol. 2021. PMID: 34168659 Free PMC article. Review. - Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.
Lee NS, Barber L, Kanchwala A, Childs CJ, Kataria YP, Judson MA, Mazer MA, Arce S. Lee NS, et al. Clin Vaccine Immunol. 2011 Feb;18(2):223-34. doi: 10.1128/CVI.00469-10. Epub 2010 Dec 22. Clin Vaccine Immunol. 2011. PMID: 21177920 Free PMC article. - A self-inactivating retrovector incorporating the IL-2 promoter for activation-induced transgene expression in genetically engineered T-cells.
Jaalouk DE, Lejeune L, Couture C, Galipeau J. Jaalouk DE, et al. Virol J. 2006 Nov 21;3:97. doi: 10.1186/1743-422X-3-97. Virol J. 2006. PMID: 17118192 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials